$68.64
0[0.00%]
Last update: 4:00PM Get Real Time Here
Stride Stock (NYSE:LRN), Analyst Ratings, Price Targets, Predictions
Stride Inc has a consensus price target of $62.67, established from looking at the 32 latest analyst ratings. The last 3 analyst ratings were released from BMO Capital, Barrington Research, and Barrington Research on April 25, 2024, April 24, 2024, and April 17, 2024. With an average price target of $74.33 between BMO Capital, Barrington Research, and Barrington Research, there's an implied 8.29% upside for Stride Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Barrington Research
Citigroup
Morgan Stanley
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Stride
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | Buy Now | 6.35% | BMO Capital | Jeffrey Silber | $72 → $73 | Maintains | Outperform | Get Alert |
| 04/24/2024 | Buy Now | 9.27% | Barrington Research | Alexander Paris | $75 → $75 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 9.27% | Barrington Research | Alexander Paris | $75 → $75 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | 9.27% | Citigroup | Thomas Singlehurst | $70 → $75 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | 4.9% | BMO Capital | Jeffrey Silber | $71 → $72 | Maintains | Outperform | Get Alert |
| 01/24/2024 | Buy Now | -5.3% | Morgan Stanley | Greg Parrish | $60 → $65 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | Buy Now | 9.27% | Barrington Research | Alexander Paris | $70 → $75 | Maintains | Outperform | Get Alert |
| 12/04/2023 | Buy Now | 1.98% | Barrington Research | Alexander Paris | → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 11/16/2023 | Buy Now | -2.39% | BMO Capital | Jeffrey Silber | $57 → $67 | Maintains | Outperform | Get Alert |
| 11/16/2023 | Buy Now | -12.59% | Morgan Stanley | Greg Parrish | $57 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/26/2023 | Buy Now | -16.96% | BMO Capital | Jeffrey Silber | $50 → $57 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -12.59% | Barrington Research | Alexander Paris | $50 → $60 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -16.96% | Morgan Stanley | Greg Parrish | $52 → $57 | Maintains | Equal-Weight | Get Alert |
| 08/16/2023 | Buy Now | -27.16% | Barrington Research | Alexander Paris | → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 08/16/2023 | Buy Now | -24.24% | Morgan Stanley | Greg Parrish | $50 → $52 | Maintains | Equal-Weight | Get Alert |
| 08/16/2023 | Buy Now | -27.16% | BMO Capital | Jeffrey Silber | $49 → $50 | Maintains | Outperform | Get Alert |
| 04/26/2023 | Buy Now | -27.16% | Morgan Stanley | Greg Parrish | $46 → $50 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | Buy Now | -27.16% | Barrington Research | Alexander Paris | → $50 | Reiterates | → Outperform | Get Alert |
| 03/10/2023 | Buy Now | -32.98% | Morgan Stanley | Greg Parrish | → $46 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/26/2023 | Buy Now | -30.07% | BMO Capital | Jeffrey Silber | $47 → $48 | Maintains | Outperform | Get Alert |
| 01/25/2023 | Buy Now | -27.16% | Barrington Research | Alexander Paris | → $50 | Reiterates | → Outperform | Get Alert |
| 01/25/2023 | Buy Now | -32.98% | Morgan Stanley | Greg Parrish | $41 → $46 | Maintains | Overweight | Get Alert |
| 01/04/2023 | Buy Now | -40.27% | Morgan Stanley | Greg Parrish | $43 → $41 | Maintains | Overweight | Get Alert |
| 10/27/2022 | Buy Now | -27.16% | BMO Capital | Jeffrey Silber | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/27/2022 | Buy Now | -37.35% | Morgan Stanley | Toni Kaplan | $47 → $43 | Maintains | Overweight | Get Alert |
| 09/27/2022 | Buy Now | -31.53% | Morgan Stanley | Toni Kaplan | $45 → $47 | Maintains | Overweight | Get Alert |
| 08/25/2022 | Buy Now | -34.44% | Morgan Stanley | Greg Parrish | → $45 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/10/2022 | Buy Now | -34.44% | Morgan Stanley | Jeffrey Goldstein | $42 → $45 | Maintains | Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | -38.81% | Morgan Stanley | Jeffrey Goldstein | $39 → $42 | Maintains | Equal-Weight | Get Alert |
| 04/20/2022 | Buy Now | -43.18% | Morgan Stanley | Jeffrey Goldstein | $36 → $39 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Stride (LRN)?
The latest price target for Stride (NYSE: LRN) was reported by BMO Capital on April 25, 2024. The analyst firm set a price target for $73.00 expecting LRN to rise to within 12 months (a possible 6.35% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Stride (LRN)?
The latest analyst rating for Stride (NYSE: LRN) was provided by BMO Capital, and Stride maintained their outperform rating.
When was the last upgrade for Stride (LRN)?
The last upgrade for Stride Inc happened on August 25, 2022 when Morgan Stanley raised their price target to $45. Morgan Stanley previously had an equal-weight for Stride Inc.
When was the last downgrade for Stride (LRN)?
The last downgrade for Stride Inc happened on March 10, 2023 when Morgan Stanley changed their price target from N/A to $46 for Stride Inc.
When is the next analyst rating going to be posted or updated for Stride (LRN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stride, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stride was filed on April 25, 2024 so you should expect the next rating to be made available sometime around April 25, 2025.
Is the Analyst Rating Stride (LRN) correct?
While ratings are subjective and will change, the latest Stride (LRN) rating was a maintained with a price target of $72.00 to $73.00. The current price Stride (LRN) is trading at is $68.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.